Dermoaroma
Dermoaroma is a privately held Italian pharmaceutical company founded in 2009 that develops and distributes CE-marked regenerative aesthetic products and medical devices based on proprietary bovine colostrum-derived secretome technology to medical professionals and aesthetic clinics in 60 countries.
- Company typePrivate
- Founded2009
- HeadquartersBrusciano, Italy
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dermoaroma does
Dermoaroma is a privately held Italian pharmaceutical company founded in 2009 that develops, manufactures, and distributes regenerative aesthetic products and CE-marked medical devices for dermatology, trichology, and aesthetic medicine practitioners. Its proprietary AMPLEX Plus technology platform produces purified secretomes (exosomes) and growth factors derived from organic bovine colostrum, formulated into a portfolio of branded product lines including Purasomes (anti-aging, skin glow, hair restoration, intimate care, and oral supplement variants), the Hybrid Peel medical device system, DPG PRP kits for autologous platelet-rich plasma preparation, Volomis hyaluronic acid dermal fillers, and the MesoAroma mesotherapy range.
The company operates a vertically integrated value chain spanning organic raw material sourcing in Sicily, manufacturing facilities in Naples, Catania, and Misterbianco, and an R&D center in Bologna, supported by ISO 9001, 13485, 22716, 14001, and 45001 certifications and CE marking across medical device Classes IIa, IIb, and III. Dermoaroma monetizes through direct B2B sales to licensed medical professionals and aesthetic clinics, complemented by exclusive distribution agreements spanning 60 countries and direct regional offices in Malta, the United States (Orlando), and the UAE (Dubai). Its primary customers are medical aesthetic practitioners, dermatologists, trichologists, regenerative medicine clinics, aesthetic spas, and gynecological practices, with the company reporting 14 registered scientific patents and active presence at major industry congresses including AMWC and IMCAS.
Dermoaroma firmographics
Firmographics- Name
- Dermoaroma
- Legal name
- Dermoaroma Italy S.R.L.
- Website
- https://dermoaroma.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Dermoaroma is a privately held Italian pharmaceutical company founded in 2009 that develops and distributes CE-marked regenerative aesthetic products and medical devices based on proprietary bovine colostrum-derived secretome technology to medical professionals and aesthetic clinics in 60 countries.
- Ownership category
- akta.pro rank
Dermoaroma industry classification
Industry- Product category
- Dermatology Medical Devices
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Dermatology Specialty Pharmaceuticals (HLAIACAL)
- akta.pro secondary industries
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Professional Skincare & Facial Treatments (CRABALAF), Dermatology & Topical Skin Treatments (HLAIADAE)
Keywords
Where Dermoaroma is headquartered
LocationHeadquarters
- HQ city
- Brusciano
- HQ country
- Italy
- HQ region
- Europe
Offices8 records
Markets served
Dermoaroma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Product Sales - Cosmeceuticals: Sale of proprietary regenerative aesthetic products including Purasomes (skin and hair formulations), mesotherapy products, and skincare supplements to medical professionals and clinics.
- Medical Devices: CE-marked medical devices including PRP kits (DPG PRP), dermal fillers (Volomis HA fillers), and hybrid peel systems sold to healthcare providers and aesthetic clinics.
- Distribution Agreements: Exclusive distribution agreements with partners in various countries for commercialization of biotechnology products and medical devices.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Dermoaroma product offering
Product offeringCore offering
Dermoaroma manufactures and sells CE-marked medical devices and cosmeceuticals for licensed medical professionals and aesthetic clinics. The portfolio includes exosome-based Purasomes formulations (anti-aging, skin glow, hair restoration, intimate care, and oral supplement), the Hybrid Peel system (Class IIB chemical peeling medical device with specialized variants), PRP kits (DPG PRP system), hyaluronic acid dermal fillers (Volomis), and MesoAroma mesotherapy products. All offerings are powered by the proprietary AMPLEX Plus technology derived from organic bovine colostrum secretomes and growth factors, supported by 14 registered patents.
Product overview
Dermoaroma offers a comprehensive portfolio of regenerative aesthetic products organized under distinct brands. The core offerings include Purasomes (a multi-product line of skin and hair formulations: NC150+ for anti-aging, SGC100+ for skin glow, HSC50+ for hair restoration, IRC100+ for intimate care in gender-specific versions, and XCell oral supplement), the Exosomal Liquid Laser protocol, and the Hybrid Peeling System (Class IIB medical device with specialized variants: Juvena, Restructa, Radiance, Cell Renew, Intima, plus technical products GF20 and H8). The DPG PRP System provides autologous platelet-rich plasma kits for tissue regeneration across multiple medical fields. Volomis delivers cross-linked hyaluronic acid dermal fillers in three strengths. MesoAroma provides an extensive mesotherapy range including cocktails, complexes, lipolytics, and mono-components. All products leverage the proprietary AMPLEX Plus technology based on secretomes and growth factors derived from organic bovine colostrum.
Differentiator
Problem solved
Functional benefit
Brands
- Purasomes: Multi-patented anti-aging, skin glowing and hair restoring formulations with organic colostrum derived exosomes, growth factors and biologically active elements. Includes NC150+, SGC100+, HSC50+, IRC100+ variants.
- Exosomal Liquid Laser
- Hybrid Peel
- DPG PRP
- Volomis
- MesoAroma
Products and services
- Purasomes NC150+ Anti-aging skin regeneration formulation with organic colostrum-derived exosomes, growth factors, and bioactive elements. Contains 20 billion exosomes, 20 functional growth factors, PDRN, DMAE, Copper Gluconate, Glutathione, Vitamin C derivative, and hyaluronic acid. Designed for licensed medical professionals performing regenerative aesthetic treatments.
- Purasomes SGC100+ Skin glow complex formulation for revitalizing skin radiance and rebuilding flawless complexion. Contains 20 billion organic colostrum exosomes, 20 functional factors, pomegranate stem cells, and Vitamin C derivative. Targets melanosynthesis and melanotransportation to reduce pigment formation and improve overall skin tone.
- Purasomes HSC50+ Hair rescue formula to restore normal hair growth synchrony by resetting hair bulb function through exosomes and growth factors. Combines 20 billion exosomes, 20 functional growth factors, Curcuma longa stem cells, and peptide complex to prevent hair apoptosis and create optimal environment for healthier, thicker hair regrowth.
- Purasomes IRC100+ for Women Intimate care solution for women's reproductive health targeting menopausal complications, endometriosis, vulvar infections, post-chemotherapy recovery, post-surgery healing, and post-childbirth recovery. Includes 2.5ml solution (2 vials) for in-office treatment and 50ml regenerative gel for home use with immune response factors, growth factors, and microbiome support.
- Purasomes IRC100+ for Men Intimate care solution for men addressing erectile dysfunction and sexual performance. Combines professional in-office treatment (20 growth factors from organic bovine colostrum) with at-home bioregenerative gel containing exerkines and natural warming agents targeting improved circulation, firmness, sensory experience, and sexual stamina.
- Purasomes XCell Oral supplement in sublingual liquid form (100ml non-toxic glass bottle) combining organic bovine colostrum, Blue Icelandic Spirulina, Astragalus, DracoBelle Nu, and Vitamin B12. Supports skin health, hair growth, gastrointestinal function, immune system, and healthy telomere length through gut-skin axis support.
- Exosomal Liquid Laser Protocol for non-invasive skin rejuvenation delivering results comparable to laser resurfacing with minimal downtime. Addresses aging, skin laxity, post-acne scarring, fine lines, wrinkles, hyperpigmentation, UV damage, and dehydration. Available in Skin Rejuvenation, Skin Perfecting, and Skin Tightening protocols.
- Peeling System Juvena Peeling formulation for chrono and photoaging treatment. Instantly smoothes rough skin, provides better density and elasticity, and enhances active stability. Contains PRDN, meristematic cells of xanthoxylum piperitum, nanogel HA derivative, stem cells of wild olive tree sprouts, micro-encapsulated oligopeptide 20, and micro-encapsulated retinol.
- Peeling System Restructa Peeling formulation for acne, skin flaccidity, and mild cutaneous hyperchromia. Features synergistic antibacterial, lightening, and antioxidative action with improved stability. Contains shikimic acid, copper PCA, micro-encapsulated vitamin C derivative, pyrrolidone carboxylic acid, DMAE, lactic acid, mandelic acid, and pyruvic acid.
- Peeling System Radiance Peeling formulation for melasma, post-inflammatory hyperpigmentation, brown spots, freckles, photoaging, active acne, and wrinkle reduction. Contains micro-encapsulated resorcinol (30x more powerful than hydroquinone), azelaic acid, azeloglicine, micro-encapsulated oligopeptide 34, and glutathione.
- Peeling System Cell Renew Peeling formulation for irregular skin tone, age spots, hyperpigmentation, cutaneous/epidermal melasma, fine wrinkles, and acne scars. Contains Trichloroacetic Acid 35%, micro-encapsulated glycolic acid, meristematic cells of daucus carota sativa callus lysate, aminobutyric acid, and citric acid.
- Peeling System Intima Peeling formulation for intimate areas targeting labia majora, perianal area, inguinal area, armpits, elbows, knees, buttocks, and areolas. Lightens and firms intimate areas with Trichloroacetic Acid 3%, alfa arbutin, micro-encapsulated vitamin C, and tranexamic acid.
- DPG PRP System Autologous tissue regenerating system for platelet-rich plasma preparation. Latest generation PRP kits with CE marking (Class IIa Medical Device) and FDA 21 CFR Part 820 validation. Includes specialized tubes, centrifuge equipment, and accessories. Used in aesthetics, wound management, trichology, orthopedics, dermatology, gynecology, plastic surgery, ophthalmology, dentistry, and maxillofacial surgery.
- Volomis HA Fillers New generation cross-link hyaluronic acid dermal fillers using multi-staged cross-linking technology. Three-layered small beads for long-lasting results (6-12 months). Products include Volomis Soft, Volomis Medium, and Volomis Strong. Manufactured in Italy without animal-derived materials or organic solvents.
- MesoAroma Mesotherapy Range Complete range of aesthetic mesotherapy products designed in Bologna, Italy. Includes Meso Cocktails (Firm, CL, SC, Regen, Lift, Local CL, Hair, Bio Oxin, Antiage), Meso Complex (VITComplex, NutriComplex), Mono Components (SLC/DMAE, SLC, Q10, HA1 & HA2, DMAE, BXT Like), Meso Lipolytic (L-Carnitine, PC, Melilotus, Rutina, GSH, GBE, CA IVY, ALEs), Meso Plus, and Meso Vitamins.
Quantifiable outcome
- 16 years of excellence in regenerative aesthetics with products serving clients in 60 countries worldwide
- +1 more outcomes
Companies that use Dermoaroma
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles4 records
Dermoaroma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Dermoaroma partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Dermoaroma competitors and assessment
Company assessmentBroad incumbents
- Galderma: Global dermatology-focused pharmaceutical company offering prescription aesthetics, dermal fillers, and skincare. Comparable as a major dermatology player serving aesthetic practitioners with a portfolio including fillers (Restylane) and skin treatments, though at significantly larger scale than Dermoaroma.
- Merz Aesthetics: Global aesthetics business within Merz Group offering dermal fillers (Belotero, Radiesse), botulinum toxin (Xeomin), and skincare devices. Comparable as a multi-brand aesthetics player with CE-marked medical devices and global distribution targeting the same practitioner channel as Dermoaroma.
- SkinCeuticals (L'Oréal): Professional skincare brand within L'Oréal Dermatological Beauty offering medical-grade skincare sold through physicians and aesthetic clinics. Comparable as a dermatology-focused professional skincare brand, though SkinCeuticals operates at significantly larger scale with broader retail reach.
- AbbVie Allergan Aesthetics: Aesthetics division of AbbVie offering Botox, CoolSculpting, Juvéderm fillers, and SkinMedica skincare. Comparable as the dominant global aesthetics incumbent with overlapping regenerative and anti-aging product categories where Dermoaroma competes.
- IBSA Pharma: Swiss pharmaceutical company offering hyaluronic acid injectables, dermatology, and aesthetic medicine products globally. Comparable as an established aesthetic dermatology player with similar hyaluronic acid filler (comparable to Volomis) and regenerative offerings sold to practitioners.
Direct peers
- Benev Company: US-based medical aesthetics company offering regenerative skincare, exosome products, and PRP kits sold to medical professionals. Comparable as a similarly-sized regenerative aesthetics specialist with practitioner-channel distribution and CE-marked offerings.
- ExoCoBio: South Korea-based exosome-focused biotech developing regenerative aesthetic and therapeutic products from stem cell-derived exosomes. Directly comparable as a fellow exosome/secretome platform targeting aesthetic and dermatology practitioners.
- Kimera Labs: US-based biotechnology company specializing in exosome-based regenerative aesthetic products sold to medical professionals. Comparable as a direct exosome/regenerative aesthetics peer with practitioner-focused distribution and similar size profile.
- Promoitalia: Italian aesthetics company offering dermal fillers, mesotherapy products, and aesthetic medical devices globally. Comparable as a fellow Italy-based aesthetics manufacturer with similar product categories (fillers, mesotherapy) and international distribution focus.
Emerging players
- BioScience GmbH: German regenerative medicine company offering PRP kits and autologous therapy systems for medical aesthetics. Comparable as a similarly-sized European regenerative aesthetics player in the PRP/platelet-derived therapy category where Dermoaroma's DPG PRP competes.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Dermoaroma social profiles
Digital presenceDermoaroma compliance and trust
Trust signalCompliance10 records
Dermoaroma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dermoaroma leadership team
Management profileNumber of profiles
Profiles1 record
Dermoaroma subsidiaries and ownership
Company hierarchySubsidiaries1 record
Dermoaroma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dermoaroma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dermoaroma
What does Dermoaroma do?
Dermoaroma manufactures and sells CE-marked medical devices and cosmeceuticals for licensed medical professionals and aesthetic clinics. The portfolio includes exosome-based Purasomes formulations (anti-aging, skin glow, hair restoration, intimate care, and oral supplement), the Hybrid Peel system (Class IIB chemical peeling medical device with specialized variants), PRP kits (DPG PRP system), hyaluronic acid dermal fillers (Volomis), and MesoAroma mesotherapy products. All offerings are powered by the proprietary AMPLEX Plus technology derived from organic bovine colostrum secretomes and growth factors, supported by 14 registered patents.
Is Dermoaroma a public or private company?
Dermoaroma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dermoaroma founded?
Dermoaroma was founded in 2009. It employs 51 to 100 people.
Where is Dermoaroma based?
Dermoaroma is headquartered in Brusciano, Italy, in the Europe region.
How does Dermoaroma make money?
Three revenue lines are on record. Product Sales - Cosmeceuticals are the primary driver. The others are medical Devices and distribution Agreements.
Who are Dermoaroma's main competitors?
Broad incumbents on record are Galderma, Merz Aesthetics, SkinCeuticals (L'Oréal), AbbVie Allergan Aesthetics and IBSA Pharma. Direct peers are Benev Company, ExoCoBio, Kimera Labs and Promoitalia. BioScience GmbH is listed as an emerging player.
Does Dermoaroma have an API?
No public API is recorded for Dermoaroma.
What industry is Dermoaroma in?
Dermoaroma's product category is Dermatology Medical Devices. Its primary akta.pro industry code is HLAIACAL, Dermatology Specialty Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2844.